Serology and cytochemistry in surveillance of cytomegalovirus infection / reactivation after hematopoietic cell transplantation;Badania serologiczne i cytochemiczne w nadzorze zakażenia wirusem cytomegalii lub jego reaktywacji po przeszczepieniu komórek hematopoetycznych

Polskie Archiwum Medycyny Wewnetrznej

Volumn 103, Issue 5-6, 2000, Pages 241-246

  Łaba, Anna ^a   Koćwin, Edyta ^a   Lange, Andrzej ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Bone marrow transplantation; CMV antigenemia; CMV infection

Indexed keywords

GANCICLOVIR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALIC INCLUSION BODY DISEASE; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFANT; MIDDLE AGED; PRESCHOOL CHILD; SEROLOGY;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; FOLLOW-UP STUDIES; GANCICLOVIR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; MIDDLE AGED; SEROLOGIC TESTS;

EID: 6244245519     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Weber B., Nestler U., Rabenau H. i wsp.: Low correlation of human cytomegalovirus DNA amplification by polimerase chain reaction with cytomegalovirus disease in organ transplant recipients. J. Med. Virology, 1994, 43, 187.
2. Boeckh M., Bowden R.A., Gooddrich J.M. i wsp.: cytomegalovirus antigen detection in periphera blood leukocytes after allogenic marrow transplantation. Blood, 1992, 80, 5, 1358.
3. Couriel D., Canosa J., Engler H. i wsp.: Early reactivation of cytomegalovirus and high risk of interstitial pneumonitis following T-depleted BMT for adults with hematological malignancies. Bone Marrow. Transplant., 1996, 18, 347.
4. Glowacki L.S., Smaill F.M.: Use of immune globulin to prevent symptomatic cytomegalovirus disease in transplant recipients - A meta analysis. Clin. Transplantation, 1996, 8, 10.
5. Snydman D.R., Werner B.G., Heinze-Lagey B. i wsp.: Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal transplant recipients. N. Engl. J. Med., 1987, 317, 1049.
6. Bacigalupo A., van Lint M.T., Tedone E. i wsp.: Early treatment of CMV infections in allogenic bone marrow transplant recipients with foscarnet or ganciclovir. Bone Marrow Transplant., 1994, 13, 753.
7. Bacigalupo A., Tedone E., Isaza A. i wsp.: CMV - antigenemia after allogenic bone marrow transplantation: correlation of CMV-antigen positive cell numbers with transplant-related mortality. Bone Marrow Transplant., 1995, 16, 155.
8. Koskinen P.K., Nieminen M.S., Mattila S.P. i wsp.: The correlation between symptomatic CMV infection and CMV antigenemia in heart allograft recipients. Transplantation 1993, 55, 547.
9. Holowiecki J., Kopera M., Gaciong Z. i wsp.: Uzgodnienia w sprawie rozpoznawania, profilaktyki i leczenia zakażeń wirusem cytomegalii (CMV) u chorych z immunosupresja̧. Acta Hematol. Pol., 1998, 29, 2, 282,
10. Augustynowicz E., Dzierżanowska D.: Molecular Analysis of the Human Cytomegalovirus Strains isolated from infected infants. Acta Microbiol. Pol., 1998, 47, 373.
11. Chaushu G., Chaushu S., Slavin S. i wsp.: Salivary immunoglobulins in recipients of bone marrow grafts. III. A Longitudinal follow-up of CMV specific antibodies. Bone Marrow Transplant. 1996, 17, 237.
12. Gallant J.E., Moore R.D., Richman D.D. i wsp.: Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. JID., 1992, 166, 1223.
13. Patel R., Snydman D.R., Rubin R.H. i wsp.: Cytomegalovirus prophylaxis in solid organ transplant recipients. Transplantation, 1996, 61, 1279.
14. Soderberg C., Larsson S., Bergstedt-Lindgvist S. i wsp.: Identification of blood mononuclear cells permissive of cytomegalovirus infection in vitro. Transplant. Proc., 1993, 25, 1416.
15. von den Berg A.B., van Son W.J. Janssen R.A. i wsp.: Recovery from cytomegalovirus infection is associated with activation of peripheral blood lymphocytes, JID, 1992, 166, 1228.
16. Gerna G., Zipeto D., Percivalle E. i wsp.: Human cytomegalovirus infection of the major leukocyte subpopulations and evidencee for initial viral replication in polymorphonuclear leukocytes from viremic patients. JID, 1992, 166, 1236.
17. Hertenstein B., Hampl W., Bunjes D. i wsp.: Vivo/ /ex vivo T cell depletion for GVHD prophylaxis influences onset course of active cytomegalovirus infection and disease after BMT. Bone Marrow Transplant., 1995, 15, 387.